Coronary artery calcium scanning should be used for primary prevention: Pros and cons

JACC: Cardiovascular Imaging

Volumn 5, Issue 1, 2012, Pages 111-118

  Nasir, Khurram ^a,b,c   Shaw, Leslee J ^d   Budoff, Matthew J ^c   Ridker, Paul M ^e   Pea, Jessica M ^e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

coronary artery calcium scoring; LDL cholesterol

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL DECISION MAKING; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCANNING; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HEALTH CARE COST; HUMAN; HYPERCHOLESTEROLEMIA; MORTALITY; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIATION EXPOSURE; RISK ASSESSMENT; SCORING SYSTEM;

ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; VASCULAR CALCIFICATION;

EID: 84855787766     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.11.007     Document Type: Article

References (19)

1. P. Greenland, J.S. Alpert, G.A. Beller 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 56 2010 e50 e103
2. R. Detrano, A.D. Guerci, J.J. Carr Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 2008 1336 1345 (Pubitemid 351468410)
3. R. Erbel, S. Möhlenkamp, S. Moebus Heinz Nixdorf Recall Study Investigative Group Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis The Heinz Nixdorf Recall Study J Am Coll Cardiol 56 2010 1397 1406
4. M.J. Blaha, M.J. Budoff, A. Defilippis Association between hsCRP > 2, coronary artery calcium, and adverse events: implications for the JUPITER population: Multi-Ethnic Study of Atherosclerosis (MESA) Lancet 378 2011 684 692
5. M. Blaha, M.J. Budoff, L.J. Shaw Absence of coronary artery calcification and all-cause mortality J Am Coll Cardiol Img 2 2009 692 700
6. A. Sarwar, L.J. Shaw, M.D. Shapiro Diagnostic and prognostic value of absence of coronary artery calcification J Am Coll Cardiol Img 2 2009 675 688
7. M.J. Budoff, R.L. McClelland, K. Nasir Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J 158 2009 554 561
8. A. Rozanski, H. Gransar, L.J. Shaw Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial J Am Coll Cardiol 57 2011 1622 1632
9. Y. Arad, L.A. Spadaro, M. Roth, D. Newstein, A.D. Guerci Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St Francis Heart Study randomized clinical trial J Am Coll Cardiol 46 2005 166 172 (Pubitemid 40905146)
10. J. Shepherd, S.M. Cobbe, I. Ford West of Scotland Coronary Prevention Study Group Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
11. J.R. Downs, M. Clearfield, S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS JAMA 279 1998 1615 1622 (Pubitemid 28248586)
12. P.M. Ridker, E. Danielson, F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
13. J. Kjekshus, E. Apetrei, V. Barrios Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
14. L. Tavazzi, A.P. Maggioni, R. Marchioli Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 2008 1231 1239
15. C. Wanner, V. Krane, W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248 (Pubitemid 41058323)
16. B.C. Fellstrom, A.G. Jardine, R.E. Schmieder Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
17. G. Rose Sick individuals and sick populations Int J Epidemiol 14 1985 32 38 (Pubitemid 15109489)
18. P.M. Ridker, N. Rifai, M. Clearfield Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965 (Pubitemid 32568149)
19. Cholesterol Treatment Trialists Collaboration Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 2010 1670 1681